Assignee
SAPREME TECH BV
NL·1 granted patent·27 pending applications·1 citations·filing 2019–2025
Top patents by PatentIndex Score
28 records- 0160US2025302983A1Saponin ConjugatesSAPREME TECH BV·Filed 2024·Application pending·0 cites
- 0257US12453782B2Antibody-oligonucleotide conjugateSAPREME TECH BV·Filed 2019·Granted Oct 28, 2025·1 cites·17 claims
- 0353US2025205361A1Treatment regimens for therapeutic effector components that act via an intracellular molecular targetSAPREME TECH BV·Filed 2024·Application pending·0 cites
- 0451US2025082759A1Compositions comprising therapeutic nucleic acid and targeted saponin for the treatment of muscle-wasting disordersSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 0551US2025250564A2Compositions comprising therapeutic nucleic acid and saponin for the treatment of muscle-wasting disordersSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 0650US2026077055A1Compositions of polyplexes and saponinsSAPREME TECH BV·Filed 2023·Application pending·0 cites
- 0749US2023302140A1Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical compositionSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 0849US2023277612A1Saponin derivatives for use in medicineSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 0949US2025295800A1Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical compositionSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 1049US2023293708A1Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conjugate, therapeutic use thereofSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 1149US2023365617A1Saponin derivatives for use in medicineSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 1248US2026000783A1Antibody-drug conjugate with improved therapeutic windowSAPREME TECH BV·Filed 2025·Application pending·0 cites
- 1348US2025057971A1Targeted saponin-nucleic acid conjugates for treatment of muscle wasting disordersSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 1447US2023248844A1Combination comprising an adc or an aoc comprising a vhh, and a saponin or a ligand-saponin conjugateSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 1545US2023270872A1Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conjugate, therapeutic use thereofSAPREME TECH BV·Filed 2020·Application pending·0 cites
- 1645US2024307545A1Conjugate of saponin, oligonucleotide and galnacSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 1745US2023277680A1Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical compositionSAPREME TECH BV·Filed 2020·Application pending·0 cites
- 1844US2024115712A1Semicarbazone-based saponin conjugateSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 1943US2024066045A1Semicarbazone-based saponin conjugateSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 2042US2023256111A1Combination comprising an adc or an aoc comprising a vhh, and a saponin or a ligand-saponin conjugateSAPREME TECH BV·Filed 2020·Application pending·0 cites
- 2142US2024279684A1Cytosolic delivery of genome editing toolsSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 2242US2023248845A1Combination of an antibody-drug conjugate and an antibody-saponin conjugateSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 2342US2023293562A1Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereofSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 2442US2024115726A1Hydrazone-based saponin derivativesSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 2541US2024327829A1Conjugate of saponin, oligonucleotide and galnacSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 2640US2023263897A1Conjugate of galnac and saponin, therapeutic composition comprising said conjugate and a galnac-oligonucleotide conjugateSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 2737US2023357310A1Saponin derivatives with improved therapeutic windowSAPREME TECH BV·Filed 2020·Application pending·0 cites
- 2832US2022249674A1Bioactive saponin linked to a functional moietySAPREME TECH BV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SAPREME TECH BV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →